Biostar Pharmaceuticals Inc (BSPM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 809 | 217 | -170 | 561 | -19,997 |
| Depreciation Amortization | 2,787 | 2,027 | 1,224 | 459 | 1,828 |
| Income taxes - deferred | 981 | 534 | 231 | 360 | -2,036 |
| Accounts receivable | 4,205 | 9,250 | 8,736 | 5,457 | 6,629 |
| Other Working Capital | 2,236 | 8,738 | 7,817 | 4,446 | 6,302 |
| Other Operating Activity | -2,109 | -7,057 | -7,650 | -5,104 | 3,691 |
| Operating Cash Flow | $8,909 | $13,708 | $10,187 | $6,179 | $-3,584 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -982 | -978 | -955 | -4 | -11 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -824 |
| Other Investing Activity | -3,229 | -2,573 | 290 | 0 | -16,454 |
| Investing Cash Flow | $-4,211 | $-3,552 | $-665 | $-4 | $-17,289 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | -1,608 | -1,602 | -1,592 | 6,338 |
| Other Financing Activity | -6,458 | 0 | 0 | 0 | -792 |
| Financing Cash Flow | $-6,458 | $-1,608 | $-1,602 | $-1,592 | $5,545 |
| Exchange Rate Effect | 80 | 244 | 271 | 115 | 114 |
| Beginning Cash Position | 1,759 | 1,759 | 1,759 | 1,759 | 16,972 |
| End Cash Position | 80 | 10,551 | 9,951 | 6,457 | 1,759 |
| Net Cash Flow | $-1,679 | $8,792 | $8,192 | $4,698 | $-15,213 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,909 | 13,708 | 10,187 | 6,179 | -3,584 |
| Capital Expenditure | -982 | -978 | -955 | -4 | -33 |
| Free Cash Flow | 7,927 | 12,730 | 9,232 | 6,175 | -3,617 |